| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis
|
Ives, Natalie J.
|
|
2017
|
82 |
C |
p. 171-183
|
artikel
|
| 2 |
BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside
|
Boer, Judith M.
|
|
2017
|
82 |
C |
p. 203-218
|
artikel
|
| 3 |
Corrigendum to “Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy” [Eur J Cancer 67 (2016) 38–45]
|
Tromme, Isabelle
|
|
2017
|
82 |
C |
p. 247
|
artikel
|
| 4 |
Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score–matched cohort study
|
Hong, Namki
|
|
2017
|
82 |
C |
p. 103-114
|
artikel
|
| 5 |
Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non–small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria
|
Gandhi, Leena
|
|
2017
|
82 |
C |
p. 27-33
|
artikel
|
| 6 |
Elective unilateral nodal irradiation in head and neck squamous cell carcinoma: A paradigm shift
|
Al-Mamgani, A.
|
|
2017
|
82 |
C |
p. 1-5
|
artikel
|
| 7 |
Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit
|
Grössmann, N.
|
|
2017
|
82 |
C |
p. 66-71
|
artikel
|
| 8 |
Geographical variability in survival of European children with central nervous system tumours
|
Gatta, G.
|
|
2017
|
82 |
C |
p. 137-148
|
artikel
|
| 9 |
Germline polymorphisms on RET proto-oncogene involved in medullary thyroid carcinoma in a Druze family
|
Azzam, Naiel
|
|
2017
|
82 |
C |
p. 149-152
|
artikel
|
| 10 |
Getting under the skin
|
Lavoie, Jean Michel
|
|
2017
|
82 |
C |
p. 228-229
|
artikel
|
| 11 |
Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review
|
Hussein, Aisha A.
|
|
2017
|
82 |
C |
p. 115-127
|
artikel
|
| 12 |
Health-related quality of life results from the phase III CheckMate 067 study
|
Schadendorf, Dirk
|
|
2017
|
82 |
C |
p. 80-91
|
artikel
|
| 13 |
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper
|
Aapro, Matti
|
|
2017
|
82 |
C |
p. 193-202
|
artikel
|
| 14 |
Immune checkpoint inhibitors and elderly people: A review
|
Daste, Amaury
|
|
2017
|
82 |
C |
p. 155-166
|
artikel
|
| 15 |
Induction chemotherapy for nasopharyngeal cancer: An eternally unfinished issue?
|
Mazzola, Rosario
|
|
2017
|
82 |
C |
p. 153-154
|
artikel
|
| 16 |
Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors
|
Makarious, D.
|
|
2017
|
82 |
C |
p. 128-136
|
artikel
|
| 17 |
Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
|
Vermeulen, Marijn A.
|
|
2017
|
82 |
C |
p. 219-227
|
artikel
|
| 18 |
Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study
|
Pivot, X.
|
|
2017
|
82 |
C |
p. 230-236
|
artikel
|
| 19 |
Preoperative breast radiation therapy: Indications and perspectives
|
Lightowlers, S.V.
|
|
2017
|
82 |
C |
p. 184-192
|
artikel
|
| 20 |
Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis
|
Le Burel, Sébastien
|
|
2017
|
82 |
C |
p. 34-44
|
artikel
|
| 21 |
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition
|
Heppt, Markus V.
|
|
2017
|
82 |
C |
p. 56-65
|
artikel
|
| 22 |
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
|
Emile, Jean-François
|
|
2017
|
82 |
C |
p. 16-24
|
artikel
|
| 23 |
Recurrent bowel obstruction: unusual presentation of pembrolizumab-induced pancreatitis in annular pancreas
|
Rawson, Robert V.
|
|
2017
|
82 |
C |
p. 167-170
|
artikel
|
| 24 |
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
|
Gligorov, J.
|
|
2017
|
82 |
C |
p. 237-246
|
artikel
|
| 25 |
Significance of extranodal tumour deposits in colorectal cancer: A systematic review and meta-analysis
|
Lord, Amy C.
|
|
2017
|
82 |
C |
p. 92-102
|
artikel
|
| 26 |
Successful re-challenge with anti-BRAF and anti-MEK in a patient with symptomatic melanoma flare
|
Ibrahim, Tony
|
|
2017
|
82 |
C |
p. 25-26
|
artikel
|
| 27 |
Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy
|
Xie, Ze-Ming
|
|
2017
|
82 |
C |
p. 6-15
|
artikel
|
| 28 |
Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials
|
Schadendorf, Dirk
|
|
2017
|
82 |
C |
p. 45-55
|
artikel
|
| 29 |
Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
|
Holch, Julian Walter
|
|
2017
|
82 |
C |
p. 72-79
|
artikel
|
Tijdschrift beschrijving